经N6-甲基氨酸修饰的EphA10通过激活ERK/AKT通路促进前列腺癌的进展
Liang Hu1, Jianyong Tong1, Daxue Tian1
1Department of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, No. 365 Remin Road, Jinhua, 321000, Zhejiang, China.
Biochemical genetics
|November 26, 2025
概括
前列腺癌 (PCa) 的进展是由EphA10加速的,该基因的稳定性是由N6-甲基氨酸 (m6A) 修饰增强的. 准EphA10或其m6A调节器为PCa提供了一个潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 前列腺癌 (PCa) 是一种侵略性的恶性瘤,需要新的治疗点.
- 了解瘤进展的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究EphA10在前列腺癌进展中的作用.
- 阐明PCa.中的EphA10的调节机制,包括N6-甲基氨酸 (m6A) 修改.
主要方法:
- 生物信息学分析以确定关键基因.
- siRNA干扰用于基因淘汰.
- 点点涂抹,MeRIP-qPCR,qRT-PCR和西部涂抹,以评估m6A水平,mRNA和蛋白质表达.
- 分析ERK/AKT信号通路.
主要成果:
- 在PCa中,EphA10显著过度表达,促进了扩散,入侵和迁移.
- RBM15B调解EphA10mRNA的m6A修饰,增强其稳定性和表达.
- YTHDF1作为EphA10的m6A阅读器,进一步促进其稳定性和表达.
- 经m6A修饰的EphA10激活ERK/AKT信号通路,推动PCa的进展.
结论:
- 通过m6A修饰,PCa稳定了EphA10,激活了ERK/AKT通路,加速了癌症的进展.
- 准EphA10或其m6A调节蛋白 (写入器和读取器) 是PCa的一种有前途的治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
01:07MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
02:38Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:37Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
01:46Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K